CPHI and thousands of exhibitors promote the prosperity of pharmaceutical trade

According to IMS, the global tablet market will grow by 5% - 7% in 2011, reaching US $880 billion The global pharmaceutical market will grow at a compound annual growth rate of 4% - 7% By 2013, the whole market value is expected to exceed $975 billion The development of the tablet market is based on APIs, so the demand for APIs in the international market will grow steadily China has become the world's largest producer of APIs It is reported that in 2010, China's API exports recovered from the impact of the financial crisis, with the export volume reaching US $20.301 billion, an increase of 26.19% year on year; the export volume maintained a stable growth; the average export price rose by 2.27% API exports accounted for 51.09% of pharmaceutical products exports China has a large share in the international API market According to the export statistics in 2010, the market structure is stable, and the export volume, amount and average price are on the rise It is expected that in 2011, API exports will shift from rapid recovery growth to stable growth, driven by the continued expansion of market share in Europe and the United States and the growth of demand in emerging markets, with the growth expected to remain at about 20% At present, China can produce more than 1500 kinds of chemical APIs, of which more than 60 kinds of APIs have strong competitiveness in the international market Some important varieties such as vitamin C, vitamin E, penicillin, citric acid, antibiotics, paracetamol, etc occupy an important position in the world, and have obvious competitive advantages in large varieties The 11th world pharmaceutical raw materials China exhibition will be held in Shanghai in June this year In 2011), the leading manufacturers of these popular APIs - Huayao, Shiyao, Harbin pharmaceutical, Dongyao, Jiangshan pharmaceutical, XinHeCheng, Qilu pharmaceutical, Lukang, Jiuzhou pharmaceutical, xintianyuan, Xi'an Haotian, Zhejiang Kangle pharmaceutical and luodiya will all bring relevant products For the export-oriented CPHI China exhibition is undoubtedly an excellent opportunity for these enterprises to further occupy the international market, which will push the export volume of APIs to a climax in 2011 The brand exhibition, the classic inheritance of CPHI China, has been developing for the 11th year From the initial 6000 square meters, it has developed into the largest and highest level international exhibition in the pharmaceutical industry in Asia Nowadays, in addition to many well-known pharmaceutical enterprises at home and abroad, many small and medium-sized enterprises are also actively participating in the exhibition, and CPHI China is regarded as an important industry event for exhibition, trade, cooperation and exchange After ten years of accumulation and precipitation, the products displayed in the exhibition are rich in categories and strong in lineup, and have become the preferred purchasing destination for buyers In 2011, the exhibition area will continue to expand by nearly 15% on the basis of the previous year At that time, 88000 square meters of super large exhibition scale will gather 1 from more than 20 countries and regions around the world, More than 500 enterprises, together with "2011 world contract customized service China Exhibition", "2011 world pharmaceutical machinery, packaging equipment and materials China Exhibition" and "2011 world biochemical, analytical instruments and laboratory equipment China Exhibition" held in the same period, have built a comprehensive one-stop pharmaceutical industry trade platform for nearly 30000 professional visitors at home and abroad ICSE China, a new exhibition, was held at the same time, especially for the pharmaceutical industry cro & CMO Taiwan Shenlong, yaomingkant, Chongqing Boteng, Shanghai wisdom, Lianhua, Medici, Evonik Degussa, helvoet, Intertek, Bormioli Rocco Many well-known pharmaceutical outsourcing enterprises at home and abroad will gather here ICSE China has built a unique bridge for professionals in pharmaceutical companies, pharmaceutical raw materials, chemical intermediates, pharmaceutical preparation and other related manufacturing enterprises, as well as various R & D institutions, etc to find solutions for order processing and production During the exhibition, in cooperation with the high-end forum, senior experts from internationally renowned pharmaceutical enterprises, scientific research institutes and pharmaceutical outsourcing enterprises will be invited to participate in speeches and interactive discussions with industry elites, focusing on the exchange of hot topics such as the R & D needs of well-known pharmaceutical enterprises at home and abroad and the service forms of outsourcing companies There will be more exchange meetings for specific exhibitors to introduce new technologies and products to customers, so that buyers can have a further understanding of exhibitors NEA natural extract area will expand to 8 in 2011, 000 square meters, gathering nearly 300 well-known enterprises in the industry, Rhine, Huali, Haotian, lvzhijian, Hongjiu, Jianfeng, Nord, Huagao, Keyuan, green Jinke, huisong, Lihua, taiyanglvbao, Zhongshan, etc will all be present at the site, displaying animal and plant extracts, medicinal plants, raw materials of traditional Chinese medicine and other products, presenting a green natural storm The unique geographical location of E3 Pavilion makes the zone adjacent to fiachina, which provides an excellent one-stop purchasing opportunity for professional visitors in the pharmaceutical and health care industry Riotous forum will be popular in the whole exhibition site, combining with high-end forums, technical exchanges and other special activities at home and abroad, to push the atmosphere of the exhibition to a climax The forum will discuss the current situation, policy trend and future development of the pharmaceutical industry and other hot topics, so as to help the audience grasp the latest trends of China and even the global pharmaceutical market, and promote the further development of the international market for enterprises.